CDH5 and cardiovascular disorder: Early detection and monitoring of cardiovascular diseases (CVD) are vital for improving patient outcomes and reducing healthcare costs.1,2 One potential strategy involves identifying and measuring endothelial biomarkers indicative of vascular health and disease states, such as CD144.